The world's first vaccine against malaria is put into use in Africa
The European Drug Administration (EMA) has approved the introduction of the world's first malaria vaccine called Mosquirix in Africa.
Browse ScienceInfo articles and explainers related to GlaxoSmithKline.
9 published items.
The European Drug Administration (EMA) has approved the introduction of the world's first malaria vaccine called Mosquirix in Africa.
According to WHO experts, tens of thousands of people in West Africa will be able to test the Ebola vaccine early next year.
British pharmaceutical manufacturer GlaxoSmithKline (GSK) aims to commercialize the world's first malaria vaccine in 2014.
A malaria vaccine in Phase II of a trial showed that after 4 years of injections, the protection effect against the disease was 0%, according to AFP on March 20.
A group of researchers from the Laval University, CHU de Québec, and GlaxoSmithKline pharmaceutical company (GSK) have discovered a way to stimulate the brain's natural…
The US Food and Drug Administration (FDA) said on June 7 that it has decided to include two drugs for type 2 diabetes, Avandia and Actos, on the list of the highest-warn…
According to a recent study, a combination of two Tykerb drugs and Herceptin will cause tumors to breast cancer patients before surgery.
Scientists at GlaxoSmithKline in Hong Kong say they have successfully tested a vaccine against bird flu with a very small dose. The second test of this vaccine showed th…
GlaxoSmithKline, a British pharmaceutical firm, has announced that it has successfully created an avian flu vaccine caused by the H5N1 virus and can produce it.